Advertisement
News
Subscribe to MDT Magazine News

Rigel to Present at Jefferies Global Healthcare Conference

June 3, 2011 5:36 am | by Bio-Medicine.Org | Comments

SOUTH SAN FRANCISCO, June 3, 2011 /- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Jefferies 2011 Global Healthcare Conference in New York City on...

TOPICS:

TPI Board Reinstates Stock Repurchase Program

June 3, 2011 5:36 am | by Bio-Medicine.Org | Comments

CHENGDU, China, June 3, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today...

TOPICS:

CIO magazine Honors Life Technologies for Leadership in Information Technology

June 3, 2011 5:36 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., June 3, 2011 /- Life Technologies Corporation (NASDAQ: LIFE ) has been honored by IDG's CIO magazine as a part of the 2011 CIO 100 , an annual award program that recognizes organizations around the world that exemplify the highest level of operational and strategic...

TOPICS:
Advertisement

DURECT to Present at the Jefferies Healthcare Conference

June 3, 2011 5:36 am | by Bio-Medicine.Org | Comments

CUPERTINO, Calif., June 3, 2011 /- DURECT Corporation (Nasdaq: DRRX ) announced today that Jim Brown, President and CEO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June 7 at 4:30 p.m. Eastern time.  The conference is being held at the Grand Hyatt in New...

TOPICS:

Echo Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference

June 3, 2011 5:36 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, June 3, 2011 /- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today...

TOPICS:

Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA

June 3, 2011 3:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, June 3, 2011 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave® (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of...

TOPICS:

EuroNanoForum 2011 draws 1200 attendees to see close to market nanotechnology developments

June 3, 2011 2:35 am | by I-Micronews | Comments

1200 members of the nanotechnology community from over 50 countries gathered in Budapest, Hungary, for three days of presentations, networking and inspiration during EuroNanoForum 2011.

Nanoscale waveguide created for future photonics

June 2, 2011 4:37 pm | by I-Micronews | Comments

The first true nanoscale waveguides for next-generation on-chip optical communication systems have been demonstrated by researchers at the Lawrence Berkeley National Laboratory.

Advertisement

Cooper says 2Q earns up on contact sales

June 2, 2011 3:45 pm | by The Associated Press | Comments

Cooper Companies Inc. said Thursday that its net income soared to $35.4 million in its fiscal second quarter as contact lens sales rose. The company increased its guidance for the 2011 fiscal year.Cooper's earnings, of 73 cents per share, compare with earnings of $4.5 million, or 10 cents per...

Thermographic Imaging Systems for Breast Cancer Screening: FDA Safety Communication

June 2, 2011 2:30 pm | by U.S. Food & Drug Administration | Comments

Thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer.

TOPICS:

MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breas...

June 2, 2011 1:34 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, June 2, 2011 /- Data to be presented in a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, Illinois June 3-7 by researchers from The University of Texas MD Anderson Cancer Center and Biocept, Inc. show that a...

TOPICS:

Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions in Serum Triglycerides in Preclinical Testing

June 2, 2011 1:34 pm | by Bio-Medicine.Org | Comments

BETHESDA, Md., June 2, 2011 /- Spherix Incorporated (NASDAQ: SPEXD) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical...

TOPICS:

Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs)

June 2, 2011 1:33 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, June 2, 2011 /- Biocept, Inc. today reported that its scientists and academic collaborators will present a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, Illinois June 3-7. The poster presentation is based on...

TOPICS:

Caring for caregivers

June 2, 2011 1:33 pm | by Arizona State University | Comments

An ASU psychologist develops interventions for people taking care of loved ones with dementia.read more

TOPICS:

Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring

June 2, 2011 12:34 pm | by Bio-Medicine.Org | Comments

IRVINE, Calif., June 2, 2011 /- Masimo (NASDAQ: MASI ) announced today FDA 510(k) Clearance, CE Mark, and limited market release of the industry's first single-patient-use ear sensor.  Compared to digit sensors, the Masimo E1™ enables faster detection of oxygen saturation...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading